Physician profile
Michael Cunningham
NPI 1790895902
$179.29
in general payments reported to CMS, 2019-2025
6 companies · $41.76 in 2025
The $41.76 reported for 2025 was less than what a typical Nurse Anesthetist, Certified Registered provider received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.64 · 2022: $28.86 · 2023: $42.72 · 2024: $51.31 · 2025: $41.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $135.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $55.71 | 2021-2023 | Entyvio |
| Chiesi USA, INC. | $52.35 | 2024-2025 | Cleviprex, Kengreal |
| Heron Therapeutics, INC. | $23.79 | 2025 | Zynrelef |
| Merck Sharp & Dohme LLC | $16.93 | 2024 | Bridion |
| Intercept Pharmaceuticals, INC. | $16.09 | 2022 | |
| Mallinckrodt Hospital Products INC. | $14.42 | 2023 | Terlivaz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.